The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigens
Open accessAbstract
Neisseria meningitidis is a major cause of endemic cases and epidemics of meningitis and devastating septicemia. Although effective vaccines exist for several serogroups of pathogenic N. meningitidis, conventional vaccinology approaches have failed to provide a universal solution for serogroup B (MenB) which consequently remains an important burden of disease worldwide. The advent of whole-genome sequencing changed the approach to vaccine development, enabling the identification of potential vaccine candidates starting directly with the genomic information, with a process named reverse vaccinology. The application of reverse vaccinology to MenB allowed the identification of new protein antigens able to induce bactericidal antibodies. Three highly immunogenic antigens (fHbp, NadA and NHBA) were combined with outer membrane vesicles and formulated for human use in a multicomponent vaccine, named 4CMenB. This is the first MenB vaccine based on recombinant proteins able to elicit a robust bactericidal immune response in adults, adolescents and infants against a broad range of serogroup B isolates. This review describes the successful story of the development of the 4CMenB vaccine, with particular emphasis on the functional, immunological and structural characterization of the protein antigens included in the vaccine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome Sequencing
Pizza, M., Scarlato, V., Masignani, V., Giuliani, M. M., Aricò, B., Comanducci, M., Jennings, G. T., Baldi, L., Bartolini, E., Capecchi, B., et al. (2000) · Science · doi:10.1126/science.287.5459.1816 · Cited by 1,399
Self-citationComplete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58
Tettelin, H., Saunders, N. J., Heidelberg, J., Jeffries, A. C., Nelson, K. E., Eisen, J. A., Ketchum, K. A., Hood, D. W., Peden, J. F., Dodson, R. J., et al. (2000) · Science · doi:10.1126/science.287.5459.1809 · Cited by 1,097
Self-citationHUMAN IMMUNITY TO THE MENINGOCOCCUS
Goldschneider, I., Gotschlich, E. C., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1327 · Cited by 995
The lipocalin protein family: structural and sequence overview
Flower, D. R., North, A. C. T., & Sansom, C. E. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00148-5 · Cited by 868
Infectious diseases associated with complement deficiencies
Figueroa, J. E., & Densen, P. (1991) · Clinical Microbiology Reviews · doi:10.1128/cmr.4.3.359 · Cited by 729
A universal vaccine for serogroup B meningococcus
Giuliani, M. M., Adu-Bobie, J., Comanducci, M., Aricò, B., Savino, S., Santini, L., Brunelli, B., Bambini, S., Biolchi, A., Capecchi, B., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603940103 · Cited by 727
Self-citationSierra, G. V. G., Campa, H. C., Varcacel, N. M., Garcia, I. L., Izquierdo, P., Sotolongo, P. F., Casanueva, G. V., Rico, C. O., Rodriguez, C. R., & Terry, M. H. (1991) · PubMed · Cited by 512
Reverse vaccinology, a genome-based approach to vaccine development
Rappuoli, R. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00554-5 · Cited by 497
Self-citationMicrobial adherence to and invasion through proteoglycans
Rostand, K. S., & Esko, J. D. (1997) · Infection and Immunity · doi:10.1128/iai.65.1.1-8.1997 · Cited by 490
Holst, J., Martin, D., Arnold, R., Huergo, C. C., Oster, P., O’Hallahan, J., & Rosenqvist, E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.071 · Cited by 405
Infections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy
Ram, S., Lewis, L. A., & Rice, P. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00048-09 · Cited by 405
Self-citationVaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870
Masignani, V., Comanducci, M., Giuliani, M. M., Bambini, S., Adu-Bobie, J., Aricò, B., Brunelli, B., Pieri, A., Santini, L., Savino, S., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021911 · Cited by 395
Self-citationMadico, G., Welsch, J. A., Lewis, L. A., McNaughton, A., Perlman, D. H., Costello, C. E., Ngampasutadol, J., Vogel, U., Granoff, D. M., & Ram, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.501 · Cited by 390
Self-citationMeningococcal carriage and disease—Population biology and evolution
Caugant, D. A., & Maiden, M. C. J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.061 · Cited by 381
Hoiczyk, E., Roggenkamp, A., Reichenbecher, M., Lupas, A., & Heesemann, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.22.5989 · Cited by 359
NadA, a Novel Vaccine Candidate of Neisseria meningitidis
Comanducci, M., Bambini, S., Brunelli, B., Adu-Bobie, J., Aricò, B., Capecchi, B., Giuliani, M. M., Masignani, V., Santini, L., Savino, S., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020407 · Cited by 351
Self-citationFinne, J., Bitter-Suermann, D., Goridis, C., & Finne, U. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.12.4402 · Cited by 332
Vaccine Potential of the Neisseria meningitidis 2086 Lipoprotein
Fletcher, L. D., Bernfield, L., Barniak, V., Farley, J. E., Howell, A., Knauf, M., Ooi, P., Smith, R. P., Weise, P., Wetherell, M., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.4.2088-2100.2004 · Cited by 332
Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates
Schneider, M. C., Prosser, B. E., Caesar, J. J. E., Kugelberg, E., Li, S., Zhang, Q., Quoraishi, S., Lovett, J. E., Deane, J. E., Sim, R. B., et al. (2009) · Nature · doi:10.1038/nature07769 · Cited by 314
Trimeric autotransporter adhesins: variable structure, common function
Linke, D., Riess, T., Autenrieth, I. B., Lupas, A., & Kempf, V. A. J. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.04.005 · Cited by 307
Donnelly, J., Medini, D., Boccadifuoco, G., Biolchi, A., Ward, J., Frasch, C., Moxon, E. R., Stella, M., Comanducci, M., Bambini, S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013758107 · Cited by 297
Self-citationIdentification of a heparin-binding hemagglutinin present in mycobacteria.
Menozzi, F. D., Rouse, J. H., Alavi, M., Laude-Sharp, M., Muller, J., Bischoff, R., Brennan, M. J., & Locht, C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.993 · Cited by 281
OSTER, P., LENNON, D., OHALLAHAN, J., MULHOLLAND, K., REID, S., & MARTIN, D. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.063 · Cited by 271
Pathogenic neisseriae: surface modulation, pathogenesis and infection control
Virji, M. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2097 · Cited by 267
Boslego, J. (1995) · Vaccine · doi:10.1016/0264-410x(94)00037-n · Cited by 267
Findlow, J., Borrow, R., Snape, M. D., Dawson, T., Holland, A., John, T. M., Evans, A., Telford, K. L., Ypma, E., Toneatto, D., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/656741 · Cited by 257
Fredriksen, J. H., Rosenqvist, E., Wedege, E., Bryn, K., BJUNE, G., Frøholm, L. O., Lindbak, A.-K., Møgster, B., Namork, E., & Rye, U. (1991) · PubMed · Cited by 242
Meningococcal Meningitis: Unprecedented Incidence of Serogroup X--Related Cases in 2006 in Niger
Boisier, P., Nicolas, P., Djibo, S., Taha, M.-K., Jeanne, I., Mainassara, H. B., Tenebray, B., Kairo, K. K., Giorgini, D., & Chanteau, S. (2007) · Clinical Infectious Diseases · doi:10.1086/511646 · Cited by 237
Advances in the Development of Vaccines against Neisseria meningitidis
Tan, L. K. K., Carlone, G. M., & Borrow, R. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0906357 · Cited by 233
Functional Significance of Factor H Binding to Neisseria meningitidis
Schneider, M. C., Exley, R. M., Chan, H., Feavers, I., Kang, Y.-H., Sim, R. B., & Tang, C. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7566 · Cited by 230
Capecchi, B., Adu‐Bobie, J., Di Marcello, F., Ciucchi, L., Masignani, V., Taddei, A., Rappuoli, R., Pizza, M., & Aricò, B. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04423.x · Cited by 230
Self-citationSnape, M. D., Perrett, K. P., Ford, K. J., John, T. M., Pace, D., Yu, L.-M., Langley, J. M., McNeil, S., Dull, P. M., Ceddia, F., et al. (2008) · JAMA · doi:10.1001/jama.2007.29-c · Cited by 217
Trimeric autotransporters: a distinct subfamily of autotransporter proteins
Cotter, S. E., Surana, N. K., & St. Geme, J. W. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2005.03.004 · Cited by 211
Molecular Analysis of Transport and Oligomerization of the Yersinia enterocolitica Adhesin YadA
Roggenkamp, A., Ackermann, N., Jacobi, C. A., Truelzsch, K., Hoffmann, H., & Heesemann, J. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.13.3735-3744.2003 · Cited by 209
Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans
Serruto, D., Spadafina, T., Ciucchi, L., Lewis, L. A., Ram, S., Tontini, M., Santini, L., Biolchi, A., Seib, K. L., Giuliani, M. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915162107 · Cited by 207
Self-citationGenetic Analysis of Meningococci Carried by Children and Young Adults
Claus, H., Maiden, M. C. J., Wilson, D. J., McCarthy, N. D., Jolley, K. A., Urwin, R., Hessler, F., Frosch, M., & Vogel, U. (2005) · The Journal of Infectious Diseases · doi:10.1086/428590 · Cited by 207
Stephens, D. S. (2007) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00051.x · Cited by 202
Stephens, D. S. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.070 · Cited by 198
Borrow, R., Carlone, G. M., Rosenstein, N., Blake, M., Feavers, I., Martin, D., Zollinger, W., Robbins, J., Aaberge, I., Granoff, D. M., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.091 · Cited by 197
Self-citationSnape, M. D., Dawson, T., Oster, P., Evans, A., John, T. M., Ohene-Kena, B., Findlow, J., Yu, L.-M., Borrow, R., Ypma, E., et al. (2010) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181f59f6d · Cited by 187
Microsatellite instability regulates transcription factor binding and gene expression
Martin, P., Makepeace, K., Hill, S. A., Hood, D. W., & Moxon, E. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406805102 · Cited by 184
Interactions between Neisseria meningitidis and the complement system
Schneider, M. C., Exley, R. M., Ram, S., Sim, R. B., & Tang, C. M. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.03.005 · Cited by 181
Self-citationClaassen, I., Meylis, J., van der Ley, P., Peeters, C., Brons, H., Robert, J., Borsboom, D., van der Ark, A., van Straaten, I., Roholl, P., et al. (1996) · Vaccine · doi:10.1016/0264-410x(96)00020-5 · Cited by 175
Granoff, D. M., Welsch, J. A., & Ram, S. (2009) · Infection and Immunity · doi:10.1128/iai.01191-08 · Cited by 161
Self-citationLewis, L. A., Ngampasutadol, J., Wallace, R., Reid, J. E. A., Vogel, U., & Ram, S. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001027 · Cited by 159
Self-citationCaugant, D. A. (2008) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2008.04.002 · Cited by 145
Reverse vaccinology: a genome-based approach for vaccine development
Masignani, V., Rappuoli, R., & Pizza, M. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.8.895 · Cited by 142
Self-citationThe epidemiology of meningococcal disease and the impact of vaccines
Khatami, A., & Pollard, A. J. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.3 · Cited by 142
Rational Design of a Meningococcal Antigen Inducing Broad Protective Immunity
Scarselli, M., Aricò, B., Brunelli, B., Savino, S., Marcello, F. D., Palumbo, E., Veggi, D., Ciucchi, L., Cartocci, E., Bottomley, M. J., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002234 · Cited by 140
Self-citationKeiser, P. B., Cicatelli, S., Moran, E. E., Schmiel, D. H., Pinto, V. B., Burden, R. E., Miller, L., Moon, J. E., Bowden, R. A., Cummings, J. F., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.12.039 · Cited by 138
NadA Diversity and Carriage in Neisseria meningitidis
Comanducci, M., Bambini, S., Caugant, D. A., Mora, M., Brunelli, B., Capecchi, B., Ciucchi, L., Rappuoli, R., & Pizza, M. (2004) · Infection and Immunity · doi:10.1128/iai.72.7.4217-4223.2004 · Cited by 137
Self-citationBambini, S., Muzzi, A., Olcén, P., Rappuoli, R., Pizza, M., & Comanducci, M. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.02.098 · Cited by 134
Self-citationBeernink, P. T., Shaughnessy, J., Braga, E. M., Liu, Q., Rice, P. A., Ram, S., & Granoff, D. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003470 · Cited by 133
Self-citationNeisseria meningitidis producing the Opc adhesin binds epithelial cell proteoglycan receptors
Vries, F. P. D., Cole, R. L., Dankert, J., Frosch, M., & van Putten, J. P. M. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00763.x · Cited by 124
Hannah, J. H., Menozzi, F. D., Renauld‐Mongénie, G., Locht, C., & Brennan, M. J. (1994) · Infection and Immunity · doi:10.1128/iai.62.11.5010-5019.1994 · Cited by 119
Tondella, M. L., Popović, T., Rosenstein, N. E., et al. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.9.3323-3328.2000 · Cited by 115
Seib, K. L., Serruto, D., Oriente, F., Delany, I., Adu‐Bobie, J., Veggi, D., Aricò, B., Rappuoli, R., & Pizza, M. (2008) · Infection and Immunity · doi:10.1128/iai.01071-08 · Cited by 113
Self-citationWang, X., Cohn, A. C., Comanducci, M., Andrew, L., Zhao, X., MacNeil, J. R., Schmink, S. E., Muzzi, A., Bambini, S., Rappuoli, R., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.04.092 · Cited by 110
Self-citationWelsch, J. A., Ram, S., Koeberling, O., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/528994 · Cited by 109
Self-citationIdentification of multiple sites of interaction between heparin and the complement system
Sahu, A., & Panoburn, M. K. (1993) · Molecular Immunology · doi:10.1016/0161-5890(93)90079-q · Cited by 102
Lucidarme, J., Tan, L., Exley, R. M., Findlow, J., Borrow, R., & Tang, C. M. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00055-11 · Cited by 102
Lucidarme, J., Comanducci, M., Findlow, J., Gray, S. J., Kaczmarski, E. B., Guiver, M., Vallely, P. J., Oster, P., Pizza, M., Bambini, S., et al. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00027-10 · Cited by 102
Lo, H., Tang, C. M., & Exley, R. M. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70132-x · Cited by 97
Surana, N. K., Cutter, D., Barenkamp, S. J., & Geme, J. W. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311496200 · Cited by 92
Giuliani, M. M., Biolchi, A., Serruto, D., Ferlicca, F., Vienken, K., Oster, P., Rappuoli, R., Pizza, M., & Donnelly, J. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.05.014 · Cited by 90
Self-citationLucidarme, J., Comanducci, M., Findlow, J., Gray, S. J., Kaczmarski, E. B., Guiver, M., Kugelberg, E., Vallely, P. J., Oster, P., Pizza, M., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00936-09 · Cited by 90
Metruccio, M. M. E., Pigozzi, E., Roncarati, D., Scorza, F. B., Norais, N., Hill, S. A., Scarlato, V., & Delany, I. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000710 · Cited by 87
Genome-based approaches to develop vaccines against bacterial pathogens
Serruto, D., Serino, L., Masignani, V., & Pizza, M. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.072 · Cited by 86
Self-citationBeernink, P. T., Welsch, J. A., Bar-Lev, M., Koeberling, O., Comanducci, M., & Granoff, D. M. (2008) · Infection and Immunity · doi:10.1128/iai.00367-08 · Cited by 86
KIMURA, A. E., Toneatto, D., Kleinschmidt, A., Wang, H., & Dull, P. M. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00304-10 · Cited by 82
Litt, D. J., Savino, S., Beddek, A. J., Comanducci, M., SANDIFORD, C. P., Stevens, J., Levin, M., Ison, C., Pizza, M., Rappuoli, R., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/424464 · Cited by 71
Self-citationStructural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086
Mascioni, A., Bentley, B. E., Camarda, R., Dilts, D. A., Fink, P. S., Gusarova, V., Hoiseth, S. K., Jacob, J., Lin, S. L., Malakian, K., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m808831200 · Cited by 70
Seib, K. L., Brunelli, B., Brogioni, B., Palumbo, E., Bambini, S., Muzzi, A., Marcello, F. D., Marchi, S., ENDE, A. V. D., Aricò, B., et al. (2010) · Infection and Immunity · doi:10.1128/iai.00891-10 · Cited by 70
Self-citationHoang, L., Thomas, É., Tyler, S. D., Pollard, A. J., Stephens, G. M., Gustafson, L., McNabb, A., Pocock, I. E. T. Z. A. J., Tsang, R. S. W., & Tan, R. (2005) · Clinical Infectious Diseases · doi:10.1086/427875 · Cited by 68
Beernink, P. T., & Granoff, D. M. (2008) · Infection and Immunity · doi:10.1128/iai.00033-08 · Cited by 68
Vu, D. M., Wong, T. T., & Granoff, D. M. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.12.075 · Cited by 67
Keiser, P. B., Gibbs, B. T., Coster, T. S., Moran, E. E., Stoddard, M. B., Labrie, J. E., Schmiel, D. H., Pinto, V. B., Chen, P., & Zollinger, W. D. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.048 · Cited by 66
Giuntini, S., Reason, D. C., & Granoff, D. M. (2011) · Infection and Immunity · doi:10.1128/iai.05182-11 · Cited by 65
Findlow, H., Vogel, U. F., Mueller, J. E., Curry, A., Njanpop‐Lafourcade, B., Claus, H., Gray, S. J., Yaro, S., Traoré, Y., Sangaré, L., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/512084 · Cited by 64
Cantini, F., Veggi, D., Dragonetti, S., Savino, S., Scarselli, M., Romagnoli, G., Pizza, M., Banci, L., & Rappuoli, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.c800214200 · Cited by 64
Self-citationGiuntini, S., Reason, D. C., & Granoff, D. M. (2011) · Infection and Immunity · doi:10.1128/iai.05956-11 · Cited by 63
Nedelec, J., BOURCRAUT, J., Garnier, J. M., & Rougon, G. (1990) · Journal of Neuroimmunology · doi:10.1016/0165-5728(90)90146-e · Cited by 60
Neisseria meningitidis Adhesin NadA Targets β1 Integrins
Nägele, V., Heesemann, J., Schielke, S., Soto, L. F. J., Kurzai, O., & Ackermann, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.188326 · Cited by 51
Brunelli, B., Tordello, E. D., Palumbo, E., Biolchi, A., Bambini, S., Comanducci, M., Muzzi, A., Pizza, M., Rappuoli, R., Donnelly, J., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.11.064 · Cited by 51
Self-citationStructural Variations within the Transferrin Binding Site on Transferrin-binding Protein B, TbpB
Calmettes, C., Yu, R., Silva, L. P., Curran, D., Schriemer, D. C., Schryvers, A. B., & Moraes, T. F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.206102 · Cited by 50
Jacobsson, S., Hedberg, S. T., Mölling, P., Unemo, M., Comanducci, M., Rappuoli, R., & Olcén, P. (2009) · Vaccine · doi:10.1016/j.vaccine.2008.12.052 · Cited by 49
Self-citationScarselli, M., Cantini, F., Santini, L., Veggi, D., Dragonetti, S., Donati, C., Savino, S., Giuliani, M. M., Comanducci, M., Marcello, F. D., et al. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.12.005 · Cited by 48
Self-citationKoeberling, O., Delany, I., & Granoff, D. M. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00542-10 · Cited by 46
Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy
Pace, D. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.18 · Cited by 43
Bai, X., & Borrow, R. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.116 · Cited by 42
Koeberling, O., Seubert, A., Santos, G., Colaprico, A., Ugozzoli, M., Donnelly, J., & Granoff, D. M. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.04.095 · Cited by 41
Esposito, V., Musi, V., de Chiara, C., Veggi, D., Serruto, D., Scarselli, M., Kelly, G. P., Pizza, M., & Pastore, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.289314 · Cited by 38
Self-citationOriente, F., Scarlato, V., & Delany, I. (2009) · Journal of Bacteriology · doi:10.1128/jb.01308-09 · Cited by 37
Montanari, P., Bozza, G., Capecchi, B., et al. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01722.x · Cited by 33
Toneatto, D., Oster, P., deBoer, A. C. W., Emerson, A., dos Santos, G. F., Ypma, E., DeTora, L. M., Pizza, M., KIMURA, A. E., & Dull, P. M. (2011) · Human Vaccines · doi:10.4161/hv.7.7.15997 · Cited by 32
Koeberling, O., Welsch, J. A., & Granoff, D. M. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.092 · Cited by 31
Robbins, J. B., Schneerson, R., Xie, G.-L., Hanson, L. Å., & Miller, M. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114489108 · Cited by 28
New frontiers in meningococcal vaccines
Anderson, A. S., Jansen, K. U., & Eiden, J. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.50 · Cited by 28
Pinto, V. B., Moran, E. E., Cruz, F., Wang, X.-M., Fridman, A., Zollinger, W. D., Przysiecki, C. T., & Burden, R. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.124 · Cited by 26
Cited by
Impact of Vaccines; Health, Economic and Social Perspectives
Rodrigues, C. M. C., & Plotkin, S. A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01526 · Cited by 737
The role of vaccines in combatting antimicrobial resistance
Micoli, F., Bagnoli, F., Rappuoli, R., & Serruto, D. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00506-3 · Cited by 500
Self-citationReverse vaccinology 2.0: Human immunology instructs vaccine antigen design
Rappuoli, R., Bottomley, M. J., D’Oro, U., Finco, O., & De Gregorio, E. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151960 · Cited by 435
Self-citationBioengineering bacterial outer membrane vesicles as vaccine platform
Gerritzen, M. J. H., Martens, D. E., Wijffels, R. H., van der Pol, L., & Stork, M. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.05.003 · Cited by 290
Parikh, S. R., Andrews, N. J., Beebeejaun, K., Campbell, H., Ribeiro, S., Ward, C., White, J. M., Borrow, R., Ramsay, M. E., & Ladhani, S. N. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31921-3 · Cited by 275
Metadata
- Authors
- Serruto, D., Bottomley, M. J., Ram, S., Giuliani, M. M., & Rappuoli, R.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 30
- Pages
- B87-B97
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W2059359501
- Cited by
- 404
- References
- 99
- FWCI
- 23.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.